Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF)

Seminars in Cancer Biology

Volumn 10, Issue 5, 2000, Pages 359-366

  Mitchell, Robert A ^a   Bucala, Richard ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

Angiogenesis; Macrophage migration inhibitory factor; MAP kinases; MIF; Proliferation

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR;

ANGIOGENESIS; ANIMAL CELL; CANCER INHIBITION; CELL PROLIFERATION; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; REVIEW; TUMOR GROWTH;

EID: 0033756658     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.2000.0328     Document Type: Article

References (57)

1. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity
2. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction
3. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
4. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction
5. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice
6. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis
7. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat
8. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome
9. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor
10. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
11. MIF as a glucocorticoid-induced modulator of cytokine production
12. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis
13. Autocrine and paracrine roles for growth factors in melanoma
14. Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: A review
15. Regulation of prostatic growth and function by peptide growth factors
16. Regulation of normal and transformed tracheobronchial epithelial cell proliferation by autocrine growth factors
17. Growth factor-induced delayed early response genes
18. Control of G1 progression by D-type cyclins: Key event for cell proliferation
19. Molecular cloning of transcripts that accumulate during the late G1 phase in cultured mouse cells
20. A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens
21. Lens epithelial cell mRNA. III. Elevated expression of macrophage migration inhibitory factor mRNA in galactose cataracts
22. Enhanced expression of macrophage migration inhibitory factor in prostatic adeno-carcinoma metastases
23. Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth
24. Sustained MAP Kinase and cPLA2 activation by Macrophage Inhibitory Factor (MIF): Regulatory role in cell proliferation and glucocorticoid action
25. Tumor angiogenesis: Therapeutic implications
26. Anticancer drug targets: Approaching angiogenesis
27. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma
28. High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis
29. The hallmarks of cancer
30. Mortality and immortality at the cellular level. A review
31. A proinflammatory cytokine inhibits p53 tumor suppressor activity
32. Risk factors for biliary tract carcinogenesis
33. Acute local inflammation potentiates tumor growth in mice
34. High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints
35. Macrophage migration inhibitory factor in rheumatoid arthritis: Evidence of proinflammatory function and regulation by glucocorticoids
36. Protein expression profiles in human breast ductal carcinoma and histologically normal tissue
37. Nitric oxide and macrophage function
38. + content, and p53 accumulation
39. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
40. Glucocorticoid receptors and resistance to glucocorticoids in hematologic malignancies
41. Involvement of the cell cycle inhibitor CIP1/WAF1 in lung alveolar epithelial cell growth arrest induced by glucocorticoids
42. Distinct glucocorticoid receptor transcriptional regulatory surfaces mediate the cytotoxic and cytostatic effects of glucocorticoids
43. Induction of neurite outgrowth by interleukin-6 is accompanied by activation of STAT3 signaling pathway in a variant PC12 cell (E2) line
44. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor
45. The cyclic adenosine monophosphate-dependent protein kinase (PKA) is required for the sustained activation of mitogen-activated kinases and gene expression by nerve growth factor
46. cAMP activates MAP kinase and Elk-1 through a b-Raf-and Rap1-dependent pathway
47. Signal-transducing protein phosphorylation cascades mediated by ras/rho proteins in the mammalian cell: The potential for multiplex signalling
48. Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor
49. Induction of cytosolic phospholipase A2 by oncogenic ras in human non-small cell lung cancer
50. Arachidonic acid activates c-jun N-terminalkinase through NADPH oxidase in rabbit proximal tubular epithelial cells
51. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis-factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK
52. Secretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1
53. Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice
54. Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis
55. Antagonism of p53-dependent apoptosis by mitogen signals
56. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
57. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation